0: Seventy patients were selected from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), previously described [ 7], from contributing UK centres.
1: Inclusion criteria specified that participants provided informed written consent, were Caucasian, were over 18 years of age, and fulfilled the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria for RA [ 13].
